Our mission is to become a worldwide reference for education in the field for all professionals involved in the process to disseminate knowledge & skills of Acute Cardiovascular Care.
Our mission is to promote excellence in clinical diagnosis, research, technical development, and education in cardiovascular imaging in Europe.
Our mission is to promote excellence in research, practice, education and policy in cardiovascular health, primary and secondary prevention.
Our mission is to reduce the burden of cardiovascular disease through percutaneous cardiovascular interventions.
Improving the quality of life and reducing sudden cardiac death by limiting the impact of heart rhythm disturbances.
Our mission is to improve quality of life and longevity, through better prevention, diagnosis and treatment of heart failure, including the establishment of networks for its management, education and research.
The ESC Working Groups' goal is to stimulate and disseminate scientific knowledge in different fields of cardiology.
The ESC Councils' goal is to share knowledge among medical professionals practising in specific cardiology domains.
OUR MISSION: TO REDUCE THE BURDEN OF CARDIOVASCULAR DISEASE
Room: Plenary Theatre
Satellite symposium sponsored by Bayer HealthCare PharmaceuticalsChairpersons: F. J. Pinto (Lisbon, PT), N. Izham (Melaka, MY)12:30 Welcome address N. Izham (Melaka, MY)12:35 Warfarin inconvenient truth in Asia A. Rosman (Kuala Lumpur, MY)12:55 European guidelines for the management of AF and new oral anticoagulants F. J. Pinto (Lisbon, PT)13:15 From clinical trials to clinical practice: case studies A. Rosman (Kuala Lumpur, MY)13:25 Closing remark F. J. Pinto (Lisbon, PT)
Satellite symposium sponsored by Boehringer IngelheimChairpersons: Razali Omar (Kuala Lumpur, MY), Ahmad Nizar Jamaluddin (Subang Jaya, MY)13:30 Opening remarks Razali Omar (Kuala Lumpur, MY)13:35 Initiating and maintaining optimal anticoagulation Michael Boehm (Homburg/Saar, DE)13:55 Optimising periprocedural protection Chee Kok Han (Subang Jaya, MY)14:15 Discussion14:30 End of session
Chairpersons: M. Komajda (Paris, FR) – D. Chew Soon Ping (MY)09:20 Introduction - M. Komajda (FR), Dr K H Sim (MY)
09:30 EuroEcho Imaging 2013 - F. Pinto (PT)09:50 Heart Failure 2014 - M. Komajda (FR)10:10 EuroPRevent 2014 - L. Tokgozoglu (TR)10:30 Questions & discussions - Poh Kian Keong (SG), David Chew Soon Ping (MY), Pham Gia Khai (VN) 10:50–11:00 Break
Chairpersons: F. Pinto (Lisbon, PT), D Quek Kwang Leng (MY) 11:00 Stable coronary artery disease - M. Komajda (Paris, FR)
11:20 Discussion - D Quek Kwang Leng (MY), Eugene Reyes (PH)
11:35 Valvular Heart Disease - F Pinto (Lisbon, PT)11:55 Discussion - Pane Kesone (LA), Orathai Pacheerat (TH)
12:15 End of session
Satellite symposium sponsored by ServierChairpersons: F. Pinto (Lisbon, PT), G H Choo (Subang Jaya, MY)
12:30 Introduction - F Pinto (Lisbon, PT)
12:35 Heart rate: the new target in CVD management - G H Choo (Subang Jaya, MY)
12:50 New opportunities in the management of coronary artery disease - R. Ferrari (Ferrara, IT)
13:10 SHIFTing the heart failure patients towards a better prognosis - M Komajda (Paris, FR)
13:25 Conclusion - F Pinto (Lisbon, PT)
Chairpersons: C. Leclercq (Rennes, FR), Azhari Rosman (MY)
08:20 Hypertension - R Ferrari (Ferrara, IT)08:50 Discussion - Azhari Rosman (MY), Low Lip Ping (SG)09:05 Cardiac pacing and resynchronisation - C. Leclercq (Rennes, FR)09:35 Discussion - Bambang Budi Siswanto (ID), Ahmad Nizar Jamuluddin (MY)
Chairpersons: M. Komajda (Paris, FR) – K. H. Sim (Malaysia)
09:50 Case 1: A diabetic patient with angina pectoris - T. Gillebert (Belgium)
10:15 What do ESC Clinical Practice Guidelines say? - T. Gillebert (Belgium)
11:00 Case 2: A patient with pulmonary embolism - T. Gillebert (Belgium)
11:25 What do ESC Clinical Practice Guidelines say? - T. Gillebert (Belgium)
11:50 Conclusion - M. Komajda (Paris, FR) – K. H. Sim (Malaysia)
12:00 End of session
The ESC Global Scientific Activities Committee gratefully acknowledges the support of its 2014 annual sponsors SERVIER, Boehringer Ingelheim and Bayer HealthCare Pharmaceuticals.
Kuala Lumpur, Malaysia
Kuala Lumpur, MY
© 2017 European Society of Cardiology. All rights reserved